Stacey Bain
Director/Board Member at Catalyst Canada, Inc.
Stacey Bain active positions
| Companies | Position | Start | End |
|---|---|---|---|
Catalyst Canada, Inc.
 Catalyst Canada, Inc. Advertising/Marketing ServicesCommercial Services Part of Catalyst, Inc., Catalyst Canada, Inc. is a Canadian company that provides marketing and advertising services. The private company is based in Toronto, Canada and was founded in 2000. | Director/Board Member | - | - |
Career history of Stacey Bain
Former positions of Stacey Bain
| Companies | Position | Start | End |
|---|---|---|---|
| ACER THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2020-06-30 | - |
BioNumerik Pharmaceuticals, Inc.
 BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Corporate Officer/Principal | 2001-06-30 | - |
Training of Stacey Bain
| Texas A&M University | Doctorate Degree |
Statistics
International
| United States | 4 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Health Technology |
Catalyst Canada, Inc.
Catalyst Canada, Inc. Advertising/Marketing ServicesCommercial Services Part of Catalyst, Inc., Catalyst Canada, Inc. is a Canadian company that provides marketing and advertising services. The private company is based in Toronto, Canada and was founded in 2000. | Commercial Services |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Stock Market
- Insiders
- Stacey Bain
- Experience
